Cargando…

Correlation between hormone receptor status and depressive symptoms in patients with metastatic breast cancer

Individual differences in depressive symptoms correlate with morbidity and outcomes in breast cancer patients. We evaluated the effect of hormone receptor (HR) status on depressive symptoms in 176 women with metastatic breast cancer at diagnosis. To assess depression, the women completed Self-Rating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Xiangyu, Xu, Junnan, Ying, E, Yu, Zhifu, Sun, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584203/ https://www.ncbi.nlm.nih.gov/pubmed/28881602 http://dx.doi.org/10.18632/oncotarget.15037

Ejemplares similares

Correlation Between Age and Hormone Receptor Status in Women With Breast Cancer
por: Shah, Aamera, et al.
Publicado: (2022)

Correlation between CpG methylation profiles and hormone receptor status in breast cancers
por: Feng, Weiwei, et al.
Publicado: (2007)

Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer
por: Xu, Junnan, et al.
Publicado: (2018)

Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists
por: Jiang, Junhan, et al.
Publicado: (2021)

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
por: Keenan, Tanya E., et al.
Publicado: (2021)

Predictive and prognostic value of circulating blood lymphocyte subsets in metastatic breast cancer
por: Yang, Jian, et al.
Publicado: (2019)

Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain
por: AlZaman, Aysha S., et al.
Publicado: (2016)

Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies
por: Niu, Ying, et al.
Publicado: (2019)

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67
por: Xu, Junnan, et al.
Publicado: (2018)

Elevated tumor mutation burden and immunogenic activity in patients with hormone receptor-negative or human epidermal growth factor receptor 2-positive breast cancer
por: Xu, Junnan, et al.
Publicado: (2019)

Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status
por: Milde-Langosch, K, et al.
Publicado: (2001)

Breast weight and hormone receptor status in women with breast cancer
por: Salhab, M, et al.
Publicado: (2005)

Efficacy of chemotherapy after hormone therapy for hormone receptor–positive metastatic breast cancer
por: Mori, Ryutaro, et al.
Publicado: (2014)

Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study
por: Jiang, Xiaofan, et al.
Publicado: (2022)

DNA methylation and hormone receptor status in breast cancer
por: Benevolenskaya, Elizaveta V., et al.
Publicado: (2016)

Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression
por: Huang, Zhiqi, et al.
Publicado: (2020)

Correlation of Tumor Budding With Known Clinicopathological, Histomorphological and Hormonal Receptor Status in Patients With Invasive Breast Carcinoma
por: Rathod, Gunvanti B, et al.
Publicado: (2022)

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
por: D’Souza, Anishka, et al.
Publicado: (2018)

Association between Polyphenol Intake and Breast Cancer Risk by Menopausal and Hormone Receptor Status
por: Vitelli-Storelli, Facundo, et al.
Publicado: (2020)

Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes
por: Clelland, Elle N., et al.
Publicado: (2023)

Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study
por: Chen, Yuhai, et al.
Publicado: (2022)

Comparison of Hormone Receptor Status in Primary and Recurrent Breast Cancer
por: Saeedi Saedi, Hamid, et al.
Publicado: (2012)

Socioeconomic status and incidence of breast cancer by hormone receptor subtype
por: Akinyemiju, Tomi F., et al.
Publicado: (2015)

Tumor budding in invasive breast carcinoma: correlation with clinicopathological parameters, hormone receptor status, and survival: an observational study
por: Ozer, Songul Peltek
Publicado: (2023)

Correlation between Hormonal Statuses and Metabolic Syndrome in Postmenopausal Women
por: Ziaei, Saeideh, et al.
Publicado: (2013)

Treatment Considerations for the Management of Patients With Hormone Receptor–Positive Metastatic Breast Cancer
por: Visovsky, Constance
Publicado: (2014)

WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer
por: Poujade, Flore-Anne, et al.
Publicado: (2018)

Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer
por: Lee, Jin Sun, et al.
Publicado: (2022)

Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status
por: Jiang, He-Sheng, et al.
Publicado: (2016)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2020)

Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study
por: Wang, Yunchao, et al.
Publicado: (2015)

Associations Between Serum Reproductive Hormone Concentrations and Hormonal Receptor Status Among Postmenopausal Chinese Women With Breast Cancer: An Observational Study
por: Jiang, Chuner, et al.
Publicado: (2022)

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
por: Bian, Li, et al.
Publicado: (2020)

Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer
por: Lin, Mingxi, et al.
Publicado: (2021)

Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer
por: Lee, Eunice Yoojin, et al.
Publicado: (2023)

Association between Postpartum Nutritional Status and Postpartum Depression Symptoms
por: Lin, Yu-Hung, et al.
Publicado: (2019)

THE RELATIONSHIP BETWEEN MARITAL STATUS, COHORT, AND DEPRESSION SYMPTOMS IN TAIWAN
por: Huang, Fang-Yi, et al.
Publicado: (2019)

Assessing Interactions between Common Genetic Variant on 2q35 and Hormone Receptor Status with Breast Cancer Risk: Evidence Based on 26 Studies
por: Huang, Tao, et al.
Publicado: (2013)

10-year ASCVD risk is positively correlated with depressive symptoms in a large general population
por: Sun, Guo-Zhe, et al.
Publicado: (2019)

Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy.
por: Hargreaves, D. F., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_k0pat5sk00o72ggd22tl7tbda0